Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output

role of presynaptic 5-HT1A receptors

Roberto Invernizzi, Mario Bramante, Rosario Samanin

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

In animals given citalopram (10 mg/kg) twice daily for 14 days a further dose of 1 mg/kg, administered 24 h after the last dose, markedly increased cortical dialysate serotonin (5-hydroxytryptamine, 5-HT), but had no effect in control animals. The effect on dialysate 5-HT in the dorsal raphe was not increased by the chronic treatment. At 25 μg/kg, 8-hydroxy-2-(di-n-propylamino) tetralin, an agonist at 5-HT1A receptors, reduced cortical 5-HT output in controls but not in animals treated chronically with citalopram whereas 50 μg/kg reduced 5-HT output in both groups. These findings suggest that somatodendritic 5-HT1A receptors are desentisized after chronic treatment with citalopram and this results in facilitation of its effect on cortical dialysate 5-HT. These results also agree with the concept that the effect of 5-HT re-uptake inhibitors on increasing 5-HT output in the frontal cortex is attenuated by their simultaneous ability to activate somatodendritic 5-HT1A receptors via an increase of endogenous 5-HT in the raphe region.

Original languageEnglish
Pages (from-to)243-246
Number of pages4
JournalEuropean Journal of Pharmacology
Volume260
Issue number2-3
DOIs
Publication statusPublished - Aug 1 1994

Fingerprint

Citalopram
Receptor, Serotonin, 5-HT1A
Serotonin
Dialysis Solutions
8-Hydroxy-2-(di-n-propylamino)tetralin
Serotonin Uptake Inhibitors
Frontal Lobe

Keywords

  • 5-HT (5-hydroxytryptamine, serotonin)
  • 5-HT receptor desensitization
  • Citalopram, 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)-tetralin)
  • Microdialysis

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output : role of presynaptic 5-HT1A receptors. / Invernizzi, Roberto; Bramante, Mario; Samanin, Rosario.

In: European Journal of Pharmacology, Vol. 260, No. 2-3, 01.08.1994, p. 243-246.

Research output: Contribution to journalArticle

@article{b10afdd355b64f8180d5144714756bb8,
title = "Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors",
abstract = "In animals given citalopram (10 mg/kg) twice daily for 14 days a further dose of 1 mg/kg, administered 24 h after the last dose, markedly increased cortical dialysate serotonin (5-hydroxytryptamine, 5-HT), but had no effect in control animals. The effect on dialysate 5-HT in the dorsal raphe was not increased by the chronic treatment. At 25 μg/kg, 8-hydroxy-2-(di-n-propylamino) tetralin, an agonist at 5-HT1A receptors, reduced cortical 5-HT output in controls but not in animals treated chronically with citalopram whereas 50 μg/kg reduced 5-HT output in both groups. These findings suggest that somatodendritic 5-HT1A receptors are desentisized after chronic treatment with citalopram and this results in facilitation of its effect on cortical dialysate 5-HT. These results also agree with the concept that the effect of 5-HT re-uptake inhibitors on increasing 5-HT output in the frontal cortex is attenuated by their simultaneous ability to activate somatodendritic 5-HT1A receptors via an increase of endogenous 5-HT in the raphe region.",
keywords = "5-HT (5-hydroxytryptamine, serotonin), 5-HT receptor desensitization, Citalopram, 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)-tetralin), Microdialysis",
author = "Roberto Invernizzi and Mario Bramante and Rosario Samanin",
year = "1994",
month = "8",
day = "1",
doi = "10.1016/0014-2999(94)90344-1",
language = "English",
volume = "260",
pages = "243--246",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output

T2 - role of presynaptic 5-HT1A receptors

AU - Invernizzi, Roberto

AU - Bramante, Mario

AU - Samanin, Rosario

PY - 1994/8/1

Y1 - 1994/8/1

N2 - In animals given citalopram (10 mg/kg) twice daily for 14 days a further dose of 1 mg/kg, administered 24 h after the last dose, markedly increased cortical dialysate serotonin (5-hydroxytryptamine, 5-HT), but had no effect in control animals. The effect on dialysate 5-HT in the dorsal raphe was not increased by the chronic treatment. At 25 μg/kg, 8-hydroxy-2-(di-n-propylamino) tetralin, an agonist at 5-HT1A receptors, reduced cortical 5-HT output in controls but not in animals treated chronically with citalopram whereas 50 μg/kg reduced 5-HT output in both groups. These findings suggest that somatodendritic 5-HT1A receptors are desentisized after chronic treatment with citalopram and this results in facilitation of its effect on cortical dialysate 5-HT. These results also agree with the concept that the effect of 5-HT re-uptake inhibitors on increasing 5-HT output in the frontal cortex is attenuated by their simultaneous ability to activate somatodendritic 5-HT1A receptors via an increase of endogenous 5-HT in the raphe region.

AB - In animals given citalopram (10 mg/kg) twice daily for 14 days a further dose of 1 mg/kg, administered 24 h after the last dose, markedly increased cortical dialysate serotonin (5-hydroxytryptamine, 5-HT), but had no effect in control animals. The effect on dialysate 5-HT in the dorsal raphe was not increased by the chronic treatment. At 25 μg/kg, 8-hydroxy-2-(di-n-propylamino) tetralin, an agonist at 5-HT1A receptors, reduced cortical 5-HT output in controls but not in animals treated chronically with citalopram whereas 50 μg/kg reduced 5-HT output in both groups. These findings suggest that somatodendritic 5-HT1A receptors are desentisized after chronic treatment with citalopram and this results in facilitation of its effect on cortical dialysate 5-HT. These results also agree with the concept that the effect of 5-HT re-uptake inhibitors on increasing 5-HT output in the frontal cortex is attenuated by their simultaneous ability to activate somatodendritic 5-HT1A receptors via an increase of endogenous 5-HT in the raphe region.

KW - 5-HT (5-hydroxytryptamine, serotonin)

KW - 5-HT receptor desensitization

KW - Citalopram, 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)-tetralin)

KW - Microdialysis

UR - http://www.scopus.com/inward/record.url?scp=0028018469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028018469&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(94)90344-1

DO - 10.1016/0014-2999(94)90344-1

M3 - Article

VL - 260

SP - 243

EP - 246

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -